G. Riemekasten

2.2k total citations
22 papers, 681 citations indexed

About

G. Riemekasten is a scholar working on Pathology and Forensic Medicine, Immunology and Dermatology. According to data from OpenAlex, G. Riemekasten has authored 22 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 7 papers in Dermatology. Recurrent topics in G. Riemekasten's work include Systemic Sclerosis and Related Diseases (18 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Dermatologic Treatments and Research (5 papers). G. Riemekasten is often cited by papers focused on Systemic Sclerosis and Related Diseases (18 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Dermatologic Treatments and Research (5 papers). G. Riemekasten collaborates with scholars based in Germany, France and Italy. G. Riemekasten's co-authors include Marco Matucci‐Cerinic, László Czirják, Martin Aringer, D E Furst, Zoltán Nagy, Margitta Worm, Hans Ulrich Scherer, Dörte Huscher, Mike Oliver Becker and W. Rohde and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Lupus.

In The Last Decade

G. Riemekasten

21 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Riemekasten Germany 12 396 217 156 150 147 22 681
Alina Soare Germany 11 247 0.6× 170 0.8× 93 0.6× 93 0.6× 208 1.4× 22 665
C.P. Denton United Kingdom 11 461 1.2× 160 0.7× 155 1.0× 114 0.8× 173 1.2× 28 620
Sonia Pezet France 10 234 0.6× 103 0.5× 53 0.3× 50 0.3× 208 1.4× 13 456
Noémie Assous France 8 209 0.5× 136 0.6× 56 0.4× 204 1.4× 84 0.6× 11 481
Tatjana Mallano Germany 6 188 0.5× 100 0.5× 67 0.4× 44 0.3× 138 0.9× 7 528
Georgios Yiannopoulos Greece 8 521 1.3× 170 0.8× 130 0.8× 274 1.8× 310 2.1× 10 810
Saverio Alvaro Italy 9 137 0.3× 119 0.5× 39 0.3× 169 1.1× 34 0.2× 11 548
Wioleta Marut Netherlands 13 187 0.5× 183 0.8× 58 0.4× 52 0.3× 64 0.4× 17 420
Kenneth J. Scalapino United States 10 112 0.3× 379 1.7× 25 0.2× 176 1.2× 68 0.5× 12 706
J Haas United Kingdom 4 235 0.6× 92 0.4× 83 0.5× 50 0.3× 100 0.7× 11 422

Countries citing papers authored by G. Riemekasten

Since Specialization
Citations

This map shows the geographic impact of G. Riemekasten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Riemekasten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Riemekasten more than expected).

Fields of papers citing papers by G. Riemekasten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Riemekasten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Riemekasten. The network helps show where G. Riemekasten may publish in the future.

Co-authorship network of co-authors of G. Riemekasten

This figure shows the co-authorship network connecting the top 25 collaborators of G. Riemekasten. A scholar is included among the top collaborators of G. Riemekasten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Riemekasten. G. Riemekasten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Riemekasten, G., Patrícia Carreira, Martin Aringer, et al.. (2020). THU0363 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD) AND NORMAL VERSUS ELEVATED C-REACTIVE PROTEIN (CRP) AT BASELINE: ANALYSES FROM THE SENSCIS TRIAL. Annals of the Rheumatic Diseases. 79. 413–414. 4 indexed citations
3.
4.
Riemekasten, G., Stefan Beissert, Jörg H. W. Distler, Alexander Kreuter, & Ulf Müller‐Ladner. (2016). Digitale Ulzerationen bei systemischer Sklerose. Zeitschrift für Rheumatologie. 76(3). 228–237. 2 indexed citations
5.
Elhaï, Muriel, Christophe Meune, É. Hachulla, et al.. (2016). OP0030 Associated Factors with Mortality and Derivation of A Simple 5-Factors To Predict Mortality in Ssc-Patients in The Eustar Cohort. Annals of the Rheumatic Diseases. 75. 64–64. 1 indexed citations
6.
Aringer, Martin, Ulf Müller‐Ladner, Heinrich Burkhardt, et al.. (2015). Gemeinsame deutschsprachige Nomenklatur für die systemische Sklerose. Zeitschrift für Rheumatologie. 74(2). 100–103. 6 indexed citations
7.
Riemekasten, G. & Elise Siegert. (2014). Geschlechtsspezifische Unterschiede des Immunsystems. Zeitschrift für Rheumatologie. 73(7). 600–606. 6 indexed citations
8.
Koumakis, Eugénie, et al.. (2013). THU0014 A Regulatory Variant in CCR6 is Associated with Anti-Topoisomerase Positive Systemic Sclerosis Susceptibility. Annals of the Rheumatic Diseases. 72. A169–A169. 3 indexed citations
9.
Riemekasten, G.. (2010). Notfälle beim Sjögren-Syndrom und der systemischen Sklerose. Aktuelle Rheumatologie. 35(1). 55–60.
10.
Dieudé, Philippe, Mickaël Guedj, J. Wipff, et al.. (2010). Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Annals of the Rheumatic Diseases. 69(11). 1958–1964. 98 indexed citations
11.
Becker, Mike Oliver, Thomas Kroencke, Dörte Huscher, et al.. (2009). Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study. Annals of the Rheumatic Diseases. 69(8). 1475–1478. 86 indexed citations
12.
Herrick, Ariane L., Jane Worthington, Norberto Ortego‐Centeno, et al.. (2008). A large multicentre analysis of CTGF −945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Annals of the Rheumatic Diseases. 68(10). 1618–1620. 33 indexed citations
13.
Czirják, László, Zoltán Nagy, Martin Aringer, et al.. (2007). The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Annals of the Rheumatic Diseases. 66(7). 966–969. 96 indexed citations
14.
Foerster, John, et al.. (2006). Neutrophil respiratory burst is decreased in scleroderma and normalized by near-infrared mediated hyperthermia. Clinical and Experimental Dermatology. 31(6). 799–806. 12 indexed citations
15.
Buch, Maya H, CP Denton, Daniel E. Fürst, et al.. (2006). Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Annals of the Rheumatic Diseases. 66(2). 169–173. 69 indexed citations
16.
Allanore, Yannick, Didier Borderie, Paolo Airó, et al.. (2006). Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Annals of the Rheumatic Diseases. 66(2). 257–259. 28 indexed citations
17.
McHugh, Neil, Oliver Distler, Roberto Giacomelli, & G. Riemekasten. (2003). Non organ based laboratory markers in systemic sclerosis.. PubMed. 21(3 Suppl 29). S32–8. 32 indexed citations
18.
Hiepe, Falk, G. Riemekasten, & Anna von Mikecz. (2002). Anti-Sm-Antikörper – Markerantikörper beim systemischen Lupus erythematodes (SLE). Zeitschrift für Rheumatologie. 61(3). 306–307. 1 indexed citations
19.
Riemekasten, G., et al.. (2002). T cell reactivity against the SmD183–119 C terminal peptide in patients with systemic lupus erythematosus. Annals of the Rheumatic Diseases. 61(9). 779–785. 102 indexed citations
20.
Jacobi, Annett M., W. Rohde, M Ventz, et al.. (2001). Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 10(8). 554–561. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alina Soare Breakdown of academic impact, for papers by C.P. Denton Breakdown of academic impact, for papers by Sonia Pezet Breakdown of academic impact, for papers by Noémie Assous Breakdown of academic impact, for papers by Tatjana Mallano Breakdown of academic impact, for papers by Georgios Yiannopoulos Breakdown of academic impact, for papers by Saverio Alvaro Breakdown of academic impact, for papers by Wioleta Marut Breakdown of academic impact, for papers by Kenneth J. Scalapino Breakdown of academic impact, for papers by J Haas
Rankless by CCL
2026